[Simultaneous presence of isoenzymes CK-BB and CKm of serum creatine kinase in small-cell bronchopulmonary cancer. Limitations of the use of M subunit immuno-inhibition technics].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to P Autran.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Under the influences of the pollen season and of specific desensitization, the serum IgE concentrations undergo modifications. During the pollen season, the antigenic stimulation induces a rapid synthesis of IgE antibodies which manifest themselves by a post-seasonal pic. The immunotherapy causes an increase of the total and specific IgE during the first few months of treatment. Afterwards the serum levels decrease progressively and after two years of treatment are inferior to the initial values. The same evolution is found in all the subjects, but with variable intensities. Forming parallely are specific blocking antibodies belonging to the IgG class which play, without a doubt, a role in the clinical amelioration obtained during the firsttwo years of treatment.
Attempts to reduce the growth of house dust pyroglyphid mites by vacuum cleaning, and modifications of temperature and humidity are useful but not sufficient. Their absence in dust from hospital beds which are disinfected led the authors to test PARAGERM AK, a non toxic bactericidal and fungicidal spray. This proved highly effective as an acaricide, killing off cultures of Dermatophagoides spp. and other mites with acceptable and easily produced concentrations, thus providing a new way of combating the house dust allergy mite.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.